Evidence-based rheumatology
Keywords:
evidence-based medicine, evidence-based rheumatology, clinical practice, researchAbstract
The practice of evidence-based medicine is a process that creates the need for clinically important information about diagnosis, prognosis, therapy, and other clinical and health care problems. The objective is to emphasize the current situation of evidence-based rheumatology, highlighting the advances and limitations that the specialty has in this regard.The evidence-based rheumatology provides scientifically based recommendations for clinical practice as a result of the analysis of numerous information generated by reliable sources. In the specialty of rheumatology there is still a group of diseases in which the experience of clinical practice is what guides the work of professionals, since there is no evidence for them supported by extensive research.
Downloads
References
Haynes RB. Sackett D.L. Evidence-based medicine. A new approach to teaching the practice of medicine. Evidence-Based Medicine Working Group. JAMA, 1992, 268 (17), 2420-5
Sackett DL, Rosenberg W, Mc Gray JA, Haynes RB, Richardson WS. Evidence-based medicine: what it is and what it isn’t. BMJ, 1996; 312: 71-2
Masic I., Miokovic M., Muhamedagic B. Acta Inform Med.2008;16(4): 219–225. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789163/
Naylor C.D. Naylor C.D., Grey zones of clinical practice: some limits to evidence-based medicine, Lancet, 1995, 345 (8953), 840-2
Pispati PK. Evidence-Based Practice in Rheumatology. Suppliment to Japi. 2006, 54. Disponible en: www.japi.org
Pincus T., Yazici. H. Evidence-Based Medicine in Rheumatology: ¿How Does It Differ from Other Diseases? from book Understanding Evidence-Based Rheumatology: A Guide to Interpreting Criteria, Drugs, Trials, Registries, and Ethics. 2014 august: 1-12. doi: 10.1007/978-3-319-08374-2_1. Disponible en: https://www.researchgate. net/publication/312812786_Evidence-based_Medicine_in_ Rheumatology_How_Does_It_Differ_from_ Other_Diseases
Verhagen AP, de Vet HCW, de Bie RA, Kessels AGH, Boers M, Knipschild PG. Balneotherapy for rheumatoid arthritis and Osteoarthritis (Cochrane Review). In: The Cochrane Library, 2, 2001. Oxford: Update Software.
Cajigas JC., Ariza R., Espinosa R., Méndez C., Mirassou M., Robles M., Santillán E, Trillo GI., Ventura L., Waiss S, Bello AE., Aldrete J., Cantú AT. Guía de práctica clínica basada en la evidencia para el diagnóstico y tratamiento de la osteoartritis. Med Int Mex 2011;27(6):552-572
Eddy D. Evidence-based medicine: a unified approach. Health affairs (Project Hope), 2005; 24 (1): 9-17
Keeling SO., Alabdurubalnabi Z., Avina-Zubieta A., Barr S., Bergeron L., Bernatsky S., Bourre-Tessier J., Clarke A., Baril-Dionne A., Dutz J., Ensworth S., Fifi-Mah A., Fortin PR., Gladman DD., Haaland D., Hanly JG., Hiraki LT., Hussein S., Legault K., Levy D., Lim L., Matsos M., McDonald EG., Medina-Rosas J., Pardo Pardi J., Peschken C., Pineau C., Pope J., Rader T., Reynolds J., Silverman E., Tselios K., Suitner M., Urowitz M., Touma Z., Vinet E.,Santesso N. Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus. J Rheumatol. 2018 Oct;45(10):1426-1439. doi: 10.3899/jrheum.171459.
Lopez-Gonzalez R, Hernandez-Garcia C, Abasolo L, Morado I, Lajas C, Vadillo C, et al. Differences between rheumatology attending physicians and training residents in the management of rheumatoid arthritis in Spain. Scand J Rheumatol. 2008;37:419–26.
Combe B, Logeart I, Belkacemi MC, et al. Comparison of the long-termoutcome for patients with rheumatoid arthritis with persistent moderatedisease activity or disease remission during the first year after diagno-sis: data from the ESPOIR cohort. Ann Rheum Dis 2014, http://dx.doi.org/10.1136/annrheumdis-2013-204178.
Dadoun S, Zeboulon-Ktorza N, Combescure C, et al. Mortality in rheumatoidarthritis over the last fifty years: systematic review and meta-analysis. JointBone Spine 2013;80:29–33.
Smolen JS, Landewé R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis2014;73:492–509.
Gaujoux-Viala C, Nam J, Ramiro S, et al. Efficacy of conventional synthetic disease modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis 2014;73:510–5.
Nam JL, Ramiro S, Gaujoux-Viala C, et al. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2014;73:516–28.
Ramiro S, Gaujoux-Viala C, Nam JL, et al. Safety of synthetic and biologi-cal DMARDs: a systematic literature review informing the 2013 update ofthe EULAR recommendations for management of rheumatoid arthritis. AnnRheum Dis 2014;73:529–35.
Felson DT, Smolen JS, Wells G, et al. American College of Rheumato-logy/European League against rheumatism provisional definition of remissionin rheumatoid arthritis for clinical trials. Ann Rheum Dis 2011;70:404–13.
Singh JA, Furst DE, Bharat A, et al. 2012 update of the 2008 American Collegeof Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.Arthritis Care Res 2012;64:625–39.
De Jong PH, Hazes JM, Barendregt PJ, et al. Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results ofthe tREACH trial. Ann Rheum Dis 2013;72:72–8.
Downloads
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
